NH SPAC 2

Boditech Med Inc. provides instruments and diagnostic reagents in South Korea and internationally. Its instruments include the ichroma II immuno-analyzer for cardiac, cancer, hormone, infectious disease, autoimmune, and metabolic biomarkers; the high-throughput ichroma III; the ExAmplar compact real-time PCR system; the automated ichroma-50 immunoassay system; the handheld Hemochroma PLUS for anemia testing; the portable ichroma M3 and M2 analyzers; and the NuActor automated nucleic acid extraction system. The company also offers AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10 compact immunoassay analyzers, along with reagents for cardiac, cancer, COVID-19, hormone, infection, autoimmune, organ function, molecular diagnostics, and therapeutic drug monitoring applications, as well as Ichroma TRIAS, ALFIAS-3, and SyncNeb. Founded in 1998, Boditech Med Inc. is headquartered in Chuncheon-si, South Korea.